Gilead Sciences (GILD) Tops Q3 EPS by 94c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $143.01 +2.94%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.65, $0.94 better than the analyst estimate of $1.71. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $6.18 billion.
GUIDANCE:
Gilead Sciences sees FY2021 EPS of $7.90-$8.10, versus the consensus of $7.18. Gilead Sciences sees FY2021 revenue of $26-26.3 billion, versus the consensus of $25.12 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
